Neuroendoscopy Market

Neuroendoscopy Market Size

The global neuroendoscopy market size was valued at USD 158.5 million in 2024 and is expected to exhibit growth at a CAGR of 5.7% from 2025 to 2034. The market is estimated to be USD 166 million in 2025 and reaching USD 272.7 million by 2034. The high market growth can be attributed to the increasing number of brain tumor cases and surging demand for minimally invasive surgical procedures.

In light of the rising incidence of brain tumors globally, there is an ever-increasing demand for neuroendoscopy devices. These modern endoscopic instruments are integral to the diagnosis and treatment of tumors like gliomas, meningiomas, and pituitary adenomas. For instance, the National Brain Tumor Society reports that around 700,000 Americans are projected to be living with a brain tumor in 2024, indicating to the need for advanced surgical intervention. Given the accuracy necessary in the surgical treatment of these tumors, neuroendoscopy is a less invasive technique compared to traditional craniotomy.

Furthermore, neuroendoscopy allows the surgical treatment of more intricately located and deeper-seated brain tumors with some minimal external access, which reduces the injurious effect of the surgery on the surrounding tissues. This approach allows for the patient's faster recovery, shorter hospital stay, and overall improved outcome—and as such, it is progressively being used more widely.

Neuroendoscopy is a highly complex surgical technique that enables profound access to the brain or spinal cords pathologies through minimal form of invasiveness. With the use of an endoscope, which is a specialized instrument equipped with a bright light and a high-resolution camera, surgeons are capable of maneuvering through small incisions or natural access points to operate on the ventricles of the brain, the base of the brain, and the spine. Compared to traditional surgical methods, this technique has lower risks and shorter recovery periods.

Neuroendoscopy Market Trends

The industry is constantly driven by the ever-growing changes in technology in neurosurgery because they provide better precision and safety, resulting in enhanced outcomes of minimally invasive surgeries performed on the brain and spine. All of these changes are increasing the usage of neuroendoscopy throughout healthcare systems by changing the way that surgeons deal with complex neurological disorders.

• The latest models of neuroendoscopes use high-definition imaging, 3D viewing capability, and better illumination as an integral part, enabling surgeons to perform intricate navigations of the spinal and cranial regions much more accurately. This improves accuracy in diagnosing medical disorders and in performing surgeries, prompting more and more medical practitioners to utilize these procedures.
  
• Moreover, robotic and artificial intelligence integration into neuroendoscopy is changing the traditional view and expectations of accuracy. With robotic arms, surgeries done by neuroendoscopes are far easier and more precise. Intelligent devices provide real-time cooperative guidance in decision-making, complications are minimized, and outcomes for the patients improve greatly.
  
• The evolution in the design of the endoscope has enabled the development of more flexible, smaller devices or instruments, making it possible to carry out procedures in a much more conservative way with the least amount of trauma to the surrounding tissues. These improvements play an important role in pediatric neurosurgery and difficult regions of the anatomy.
  

Neuroendoscopy Market Analysis

Based on product, the market is classified into rigid neuroendoscopes and flexible neuroendoscopes. The rigid neuroendoscopes segment generated the highest revenue of USD 104.1 million in 2024. Also, the global market was valued at USD 150.8 million in 2023.

• A rigid neuroendoscope allows for excellent intracranial and spinal structure visualization. This is extremely helpful in performing procedures like ventriculostomies and tumor resections. The mechanisms provided with these bipedic instruments allow maximal manipulation of the gimbal. This is essential for precision surgery.
  
• Such instruments are particularly useful in dealing with cases of hydrocephalus, resection of brain tumors, and other disorders that necessitate surgery on the central nervous system. Their flexibility in use across various peripheral neuroendoscopy procedures makes them essential devices in hospitals and specialized clinics.
  

Based on application, the neuroendoscopy market is classified into transnasal neuroendoscopy, intraventricular neuroendoscopy, and transcranial neuroendoscopy. The intraventricular neuroendoscopy segment held a dominant market share in 2024 and was valued at over USD 80.6 million.

• The approach of intraventricular neuroendoscopy is used for third ventriculostomy procedures, which are successful in treating hydrocephalus. Ultrasound imaging of this condition, especially in children and old people, increases its demand. Because of its increasing popularity, this procedure is becoming more frequently utilized.
  
• Furthermore, the development of new techniques, such as structured lighting for high-resolution cameras, as well as panoramic and microscope-mounted navigation devices, has improved the accuracy and safety of intraventricular approaches. With these developments, the market growth of this component is predicted to be high.
  

Based on usability, the neuroendoscopy market is classified into reusable neuroendoscopes and disposable neuroendoscopes. The reusable neuroendoscopes segment accounted for USD 137.2 million in market revenue in 2024 and is anticipated to grow at a CAGR of 5.5% between the 2025 to 2034 period.

• Healthcare providers conducting a significant number of procedures stand to benefit from reusable neuroendoscopes. Cost-efficient over time, their long-term use justifies the initial investment. The savings accrued from having to replace the instruments infrequently are appealing from an economic standpoint.
  
• These endoscopy devices support the increasing focus on sustainability within the healthcare sector. As the industry moves towards greener practices, reducing medical waste significantly improves the environmental impact. This is especially useful for regions with strict waste-management regulations, furthering adoption.
  
• The combination of long-term financial savings and reduction of waste makes reusable neuroendoscopes appealing to a majority of healthcare institutions trying to balance economic with ecological concerns.
  
  

Based on patient, the neuroendoscopy market is classified into adult and pediatric. The adult segment is expected to drive business growth and expand at a CAGR of 5.2%, reaching over USD 214.6 million by 2034.

• There has been a vast increase in the number of neuroendoscopic surgeries performed on adults due to the rising prevalence of neurological disorders, such as gliomas, pituitary adenomas, and obstructive hydrocephalus. These conditions often require elaborate imaging modalities and precise surgical techniques, which can be performed through neuroendoscopy.
  
• Most adults, as well as the providers delivering care to them, advocate for the technological shift towards minimally invasive procedures because they result in less recovery time, fewer complications, and shorter hospital stays. These factors are equally important when addressing adult neuropathology, which makes neuroendoscopy a preferred technique.
  

Based on end use, the neuroendoscopy market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, and other end users. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 107.1 million by the end of the forecast period.

• The vast majority of hospitals perform surgical procedures involving the brain and spinal cord, including tumor resections and treatment for hydrocephalus. There is a growing trend in the prevalence of neurosurgical procedures due to the increase in the number of people suffering from neurological disorders, which creates a need for neuroendoscopic procedures.
  
• As with any surgery, the accuracy and outcome of the procedure significantly depend on the technology used. For this reason, hospitals are allocating more resources to high-precision devices like high-definition neuroendoscopes. The purchase and implementation of these devices help this segment maintain a significant share of the market.
  

The U.S. neuroendoscopy market accounted for USD 56.1 million in market revenue in 2024 and is anticipated to grow at a CAGR of 4.8% between the 2025 to 2034 period.

• The increasing incidence of neurological disorders, such as brain tumors, epilepsy, and neurovascular diseases, is fostering the need for efficiently treated, minimally invasive procedures with low recovery time, like neuroendoscopic surgeries.
  
• Moreover, the U.S. market is further driven by the adoption of the new robotic neuroendoscope with an integrated high-definition imaging system.
  

In the Europe neuroendoscopy market, France is projected to grow remarkably in the coming years.

• Not only is the growing French population increasingly afflicted by neurovascular diseases, but the country's aging society also shows a heightened predisposition to neurological disorders, driving the demand for more sophisticated neuroendoscopic procedures.
  
• Given the simple execution process and reduced operational complications, France has adopted neuroendoscopy as its default form of performing brain surgeries.
  
• In addition, the development of neuroendoscopy systems is aided by France's powerful position in the Europe regarding healthcare and medical devices policy.
  

In the Asia neuroendoscopy market, Japan is projected to grow remarkably in the coming years.

• The increased prevalence of aging-related neurological disorders, such as brain aneurysms, along with the increased focus on minimally invasive procedures, has driven growth in the market.
  
• Japan is also a frontrunner in the development and application of specialized neuroendoscopic techniques, particularly in neuro-oncology and interventional neuroradiology, which increases the need for sophisticated neuroendoscopic devices.
  

Neuroendoscopy Market Share

The top five companies hold a 30% market share in the market. These leading players include Karl Storz, B. Braun, adeor Medical, Machida Endoscope, and Advanced Biologics. The market is experiencing growth due to the involvement of various international and national stakeholders. Several factors contribute to shifts in market share, including technological advancements, the granting of new patents, industry mergers and acquisitions, and the development of more efficient and minimally invasive devices. Established firms dominate this market by prioritizing advancements in technology and product quality.

The interplay between established companies and emerging biotech startups fosters a competitive environment where both product and price competitiveness are key. Additionally, the adoption of neuroendoscopy devices is supported by collaborations between medical device manufacturers and healthcare institutions, which further enhance marketing efforts. The increasing demand driven by the rising prevalence of neurological disorders and the growing aging population continues to drive market expansion. The market also sees frequent mergers, geographical expansion, and continuous development of new product versions.

Neuroendoscopy Market Companies

Prominent players operating in the neuroendoscopy industry include:

• Ackermann
• adeor MEDICAL
• ADVANCED BIOLOGICS
• Advin Health care
• B. Braun
• Chongqing Xishan Science & Technology
• CLARUS MEDICAL
• joimax
• KARL STORZ
• Machida
• SCHINDLER ENDOSKOPIE TECHNOLOGIE
  
• Adeor Medical – The company specializes in developing and manufacturing advanced surgical equipment, with a strong focus on neurosurgery, ENT, gynecology, and vascular surgery. Their commitment to targeted innovation, product safety, and improved efficiency makes them a trusted partner for forward-thinking surgeons.
  
• B. Braun – The firm is known for its advanced medical products and solutions such as surgical sutures and IV containers. They are a leader in providing innovative medical technology that ensures patient safety and quality, making them a trusted partner in healthcare.
  

Neuroendoscopy Industry News:

• In October 2023, Joimax unveiled its latest innovation, the iLESSYS biportal interlaminar endoscopic surgical system, designed for treating spinal disorders. This new product launch helped the company expand its customer base and reach more healthcare providers.
  

The neuroendoscopy market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Rigid neuroendoscopes
  • Rigid fiberscopes
  • Rigid videoscopes
• Flexible neuroendoscopes

Market, By Application

• Transnasal neuroendoscopy
• Intraventricular neuroendoscopy
• Transcranial neuroendoscopy

Market, By Usability

• Reusable neuroendoscopes
• Disposable neuroendoscopes

Market, By Patient

• Adult
• Pediatric

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Diagnostic centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE